September 2020 - Page 27 of 31

TuesdaySep 01, 2020 12:41 pm

RedHill Biopharma Ltd. (NASDAQ: RDHL) Featured in Virtual Coverage of The Wall Street Investor Forum

RedHill Biopharma Ltd. (Nasdaq: RDHL) is a specialty biopharmaceutical company primarily focused on gastrointestinal diseases. RedHill promotes the gastrointestinal drugs, Movantik® for opioid-induced constipation in adults, Talicia® for the treatment of Helicobacter pylori (H. pylori) infection in adults, and Aemcolo® for the treatment of travelers’ diarrhea in adults. RedHill’s key clinical late-stage development programs include: (i) RHB-204, with a planned pivotal Phase 3 study for pulmonary nontuberculous mycobacteria (NTM) infections; (ii) opaganib (Yeliva®), a first-in-class SK2 selective inhibitor targeting multiple indications with a Phase 2/3 program for COVID-19 and ongoing Phase 2 studies for prostate cancer and cholangiocarcinoma; (iii) RHB-104,…

TuesdaySep 01, 2020 12:40 pm

UGE International Ltd. (TSX.V: UGE) (OTCQB: UGEIF) Starts Presentation at The LD 500

UGE International Ltd. (TSX.V: UGE) (OTCQB: UGEIF) delivers immediate savings to businesses through the low cost of solar energy. The company helps commercial and industrial clients become more competitive by providing low-cost, distributed renewable energy solutions at no upfront cost and maximum long-term benefit. With over 400MW of global experience, UGE International works daily to power a more sustainable world. For more information, visit the company's website at www.ugei.com About The LD 500 The LD 500 is the most ambitious project in LD Micro's 14-year history of leading the micro-cap space as an independent resource. Investors will enjoy updates from…

TuesdaySep 01, 2020 12:40 pm

RadNet Inc. (NASDAQ: RDNT) Starts Presentation at The LD 500

RadNet Inc. (NASDAQ: RDNT) is the leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on number of locations and annual imaging revenue. RadNet has a network of 335 owned and/or operated outpatient imaging centers. RadNet's core markets include California, Maryland, Delaware, New Jersey and New York. In addition, RadNet provides radiology information technology solutions, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry. Together with affiliated radiologists, and inclusive of full-time and per diem employees and technicians, RadNet has a total of approximately 8,600 employees. For more…

TuesdaySep 01, 2020 12:40 pm

One Stop Systems Inc. (NASDAQ: OSS) Starts Presentation at The LD 500

One Stop Systems Inc. (NASDAQ: OSS) designs and manufactures innovative specialized high-performance computing modules and systems, including customized servers, compute accelerators, expansion systems, flash storage arrays and Ion Accelerator storage software. These products are used for deep learning, AI, defense, finance and entertainment applications, and they empower scientists, engineers, creators and other professionals to push the boundaries of their industries. OSS utilizes the power of PCI Express, the latest GPU accelerators and NVMe storage to build award-winning systems, including many industry firsts, for OEMS and government customers. The company enables AI on the Fly(R) by bringing AI datacenter performance to…

TuesdaySep 01, 2020 12:40 pm

Genasys Inc. (NASDAQ: GNSS) Starts Presentation at The LD 500

Genasys Inc. (NASDAQ: GNSS) is a global provider of critical communications systems and solutions to help keep people safe. Genasys provides a multichannel approach to deliver geotargeted alerts, notifications, instructions and information before, during and after public safety threats and critical business events. The company's unified critical communications platform includes its national emergency warning system (NEWS), personal safety service (PSS), team safety management (TSM), LRAD(R) voice broadcast systems and more. Genasys systems are in service in 72 countries and in more than 450 U.S. cities in diverse applications, including public safety, emergency warning, mass notification, critical event management, defense, law…

TuesdaySep 01, 2020 12:20 pm

Antibe Therapeutics Inc. (TSX.V: ATE) (OTCQB: ATBPF) Starts Presentation at The LD 500

Antibe Therapeutics Inc. (TSX.V: ATE) (OTCQB: ATBPF) is a biotechnology company exploiting groundbreaking advances in inflammation science. Antibe targets blockbuster opportunities to develop safer, non-addictive medicines for pain and inflammation. Antibe's technology involves the linking of a proprietary hydrogen sulfide-releasing molecule to an existing drug to produce an improved medicine. Antibe's lead drug, ATB-346, targets the global need for a safer, non-addictive drug for chronic pain and inflammation. ATB-352, the second drug in Antibe's pipeline, targets the urgent global need for a non-addictive analgesic for treating post-surgical pain, while ATB-340 is a GI-safe derivative of aspirin. Citagenix Inc., an Antibe…

TuesdaySep 01, 2020 12:20 pm

Wandisco PLC (OTC: WANSF) Starts Presentation at The LD 500

Wandisco PLC (OTC: WANSF) is the LiveData company. WANdisco solutions enable enterprises to foster an environment where data is always available, accurate and protected, creating a strong backbone for IT infrastructure and a bedrock for running consistent, accurate machine learning applications. With zero downtime and zero data loss, WANdisco LiveData Cloud Services keep geographically dispersed data at any scale consistent between on-premises and cloud environments, allowing businesses to operate seamlessly in a hybrid or multi-cloud environment. WANdisco has over a hundred customers and significant go-to-market partnerships with Microsoft Azure, Amazon Web Services, Google Cloud, Oracle and others, as well as…

TuesdaySep 01, 2020 12:20 pm

VerifyMe Inc. (NASDAQ: VRME) Starts Presentation at The LD 500

VerifyMe Inc. (NASDAQ: VRME), is a technology solutions provider specializing in brand protection functions such as counterfeit prevention, authentication, serialization and track and trace features for labels, packaging and products. VerifyMe's physical technology authenticates packaging, labels and documents with a suite of proprietary security inks and pigments, which work in conjunction with serialization and track and trace software known as VeriPAS(TM) that allows both consumers and brand inspectors to verify authenticity with their smartphones. VeriPAS is a serialization software system that brand owners access through a web portal to monitor, control and protect their products complete lifecycles. For more information,…

TuesdaySep 01, 2020 12:20 pm

Assure Holdings Corp. (OTCQB: ARHH) Starts Presentation at The LD 500

Assure Holdings Corp. (OTCQB: ARHH) works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services supporting intraoperative neuromonitoring activities during invasive surgeries. Assure employs its own staff of technologists and uses its own state-of-the-art monitoring equipment, handles 100% of intraoperative neuromonitoring scheduling and setup, and bills for all technical services provided. Assure Neuromonitoring is recognized as providing the highest level of patient care in the industry and has earned the Joint Commission's Gold Seal of Approval. For more information, visit the company's website at www.assureneuromonitoring.com About The LD 500 The LD 500 is the most ambitious…

TuesdaySep 01, 2020 12:00 pm

Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXRP) Starts Presentation at The LD 500

Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) is a global innovator in drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way active pharmaceutical ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bio-absorption; reduces time of onset; and masks unwanted tastes for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products, as well as to a world-leading tobacco producer for…